Bio-Techne Partners with Wyss Center to Enhance 3D Tissue Multiomic Analysis and Research.

Bio-Techne Partners with Wyss Center to Advance Multiomic Analysis in 3D Tissue Specimens

Bio-Techne Corporation, a prominent player in life science tools and diagnostic products, announces a strategic collaboration with the Wyss Center for Bio and Neuroengineering in Geneva. This partnership focuses on developing an automated workflow for simultaneous RNA and protein detection in three-dimensional tissue specimens. As researchers increasingly seek to understand complex biological systems, this initiative aims to enhance multiomic analysis, providing high-resolution insights that traditional methods often fail to deliver. By automating the detection process, Bio-Techne and Wyss Geneva are working to minimize reliance on outdated techniques that limit the understanding of tissue structure and cellular interactions, which are vital for advancing scientific knowledge.

The collaboration underscores Bio-Techne's commitment to advancing spatial biology, a field that combines the spatial context of biological samples with multiomic data. Matt McManus, President of Bio-Techne's Diagnostics and Spatial Biology Segment, emphasizes that this partnership is set to open new avenues in preclinical modeling, thereby enhancing drug discovery and diagnostic development. The automated workflow promises to streamline the analysis of 3D tissue specimens, enabling researchers to obtain comprehensive data that can lead to breakthroughs in understanding diseases and developing new therapies. This initiative aligns with the industry's shift toward New Approach Methodologies (NAMs), which prioritize innovative techniques such as organoids and AI-driven predictive modeling to reduce the necessity for animal testing.

Moreover, Dr. Stéphane Pages, Director of Neuroimaging at Wyss Geneva, highlights the essential nature of unlocking the potential of 3D multiomics for transforming biological understanding. Making these advanced technologies accessible to all researchers is a key goal of the collaboration. By addressing existing technical barriers and accelerating scientific progress, Bio-Techne and Wyss Geneva aim to foster ethical research practices in the life sciences sector. Through this partnership, Bio-Techne is not only expanding its spatial biology capabilities but is also poised to revolutionize research methodologies, ultimately enhancing the impact of biomedical studies and improving the quality of life through innovative healthcare solutions.

In addition to advancing research methodologies, this collaboration reflects a broader trend in the life sciences industry toward integration and automation. As companies increasingly adopt sophisticated technologies, the potential for groundbreaking discoveries grows. Bio-Techne's initiative represents a significant step forward in harnessing the power of multiomic analysis, ensuring that researchers can address the complexities of human biology more effectively.

The partnership with Wyss Center also highlights the importance of interdisciplinary collaboration in tackling some of the most pressing challenges in biomedical research. By pooling resources and expertise, Bio-Techne and Wyss Geneva aim to accelerate the development of innovative solutions that can lead to significant advancements in healthcare and therapeutic interventions.